The Silicon Therapeutics computational physics platform provides us with an exceptional ability to advance therapeutics toward curative outcomes for patients. This proprietary discovery engine, based on conformational genetics and leading-edge molecular simulations, enables us to model interactions at the atomic level and gain singular insights into critical protein targets.
Therapeutics and Pipeline
Research Pipeline
Target
Discovery
Pre-Clinical
Clinical

STING Agonist
Advanced Solid Tumors and Lymphoma

STING Agonist Combo
Cancer

STING Vaccine Adjuvant Platform
Influenza

WRN Antagonist
Cancer
Mutant-Selective Antagonist
Oncology
Allosteric Phosphatase Modulator
Oncology
Antagonist
Autoinflammatory Disease